Recovery of brain biomarkers following peroxisome proliferator-activated receptor agonist neuroprotective treatment before ischemic stroke

Proteome Science

Volumn 12, Issue 1, 2014, Pages

  Gelé, Patrick ^a,b,c,e   Vingtdeux, Valérie ^b,c   Potey, Camille ^e   Drobecq, Hervé ^c,d   Ghestem, Antoine ^b   Melnyk, Patricia ^c,d   Buée, Luc ^b,c   Sergeant, Nicolas ^b,c   Bordet, Régis ^e  

^a University of Lille   (France)

^b JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^c UNIV LILLE   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Fibrate; Neuroprotection; Proteomics; Statin; Stroke

Indexed keywords

14 3 3 ZETA PROTEIN; ALDEHYDE OXIDASE; ALPHA INTERNEXIN; ALPHA SYNUCLEIN; ATORVASTATIN; BETA SYNUCLEIN; BRAIN PROTEIN; CALVASCULIN; CHAPERONIN 60; COLLAPSIN RESPONSE MEDIATOR PROTEIN; DIHYDROPYRIMIDINASE LIKE 3 PROTEIN; DJ 1 PROTEIN; FENOFIBRATE; GLUCOSE TRANSPORTER 4; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; JANUS KINASE 2; MALATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROPROTECTIVE AGENT; PEROXIREDOXIN 2; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE A3; RAB PROTEIN; RAB16 PROTEIN; REGULATOR OF G PROTEIN SIGNALING 7; RGS PROTEIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; ISOELECTRIC POINT; LIPID METABOLISM; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; RAT; REPERFUSION INJURY; RODENT MODEL; SILVER STAINING; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNFOLDED PROTEIN RESPONSE; WESTERN BLOTTING;

RODENTIA;

EID: 84902550769     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-12-24     Document Type: Article

References (45)

1. Brass LM. Strategies for primary and secondary stroke prevention. Clin Cardiol 2006, 29:II21-7.
2. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet 1999, 354:1457-1463. 10.1016/S0140-6736(99)04407-4, 10543686.
3. Xi G, Strahle J, Hua Y, Keep RF. Progress in translational research on intracerebral hemorrhage: Is there an end in sight?. Prog Neurobiol 2014, 115:45-63.
4. Mould WA, Carhuapoma JR, Muschelli J, Lane K, Morgan TC, McBee NA, Bistran-Hall AJ, Ullman NL, Vespa P, Martin NA, Awad I, Zuccarello M, Hanley DF, . for the MISTIE Investigators Minimally Invasive Surgery Plus Recombinant Tissue-type Plasminogen Activator for Intracerebral Hemorrhage Evacuation Decreases Perihematomal Edema. Stroke 2013, 44:627-634. 10.1161/STROKEAHA.111.000411, 23391763, for the MISTIE Investigators.
5. Laufs U, Gertz K, Dirnagl U, Böhm M, Nickenig G, Endres M. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res 2002, 942:23-30. 10.1016/S0006-8993(02)02649-5, 12031849.
6. Deplanque D, Gelé P, Pétrault O, Six I, Furman C, Bouly M, Nion S, Dupuis B, Leys D, Fruchart J-C, Cecchelli R, Staels B, Duriez P, Bordet R. Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J Neurosci 2003, 23:6264-6271.
7. Deplanque D, Masse I, Lefebvre C, Libersa C, Leys D, Bordet R. Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity. Neurology 2006, 67:1403-1410. 10.1212/01.wnl.0000240057.71766.71, 17060566.
8. Chaturvedi S, Zivin J, Breazna A, Amarenco P, Callahan A, Goldstein LB, Hennerici M, Sillesen H, Rudolph A, Welch MA, . SPARCL Investigators Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology 2009, 72:688-694. 10.1212/01.wnl.0000327339.55844.1a, 18768917, SPARCL Investigators.
9. Lefebvre P, Chinetti G, Fruchart JC, Staels B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 2006, 116:571-580. 10.1172/JCI27989, 1386122, 16511589.
10. Cimini A, Benedetti E, Cristiano L, Sebastiani P, D'amico MA, D'angelo B, Di Loreto S. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons. Neuroscience 2005, 130:325-337. 10.1016/j.neuroscience.2004.09.043, 15664689.
11. Ouk T, Potey C, Gautier S, Bastide M, Deplanque D, Staels B, Duriez P, Leys D, Bordet R. PPARs: A Potential Target for a Disease-Modifying Strategy in Stroke. Curr Drug Targets 2013, 14:752-767. 10.2174/1389450111314070005, 23514380.
12. Zhou Y, Yang L, Ma A, Zhang X, Li W, Yang W, Chen C, Jin X. Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α. Neuropharmacology 2012, 63(2):242-9. 10.1016/j.neuropharm.2012.03.008, 22480617.
13. Collino M, Aragno M, Mastrocola R, Benetti E, Gallicchio M, Dianzani C, Danni O, Thiemermann C, Fantozzi R. Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: Effects of the PPAR-α agonist WY14643. Free Rad Biol Med 2006, 41:579-589. 10.1016/j.freeradbiomed.2006.04.030, 16863991.
14. Guo Q, Wang G, Namura S. Fenofibrate improves cerebral blood flow after middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 2010, 30:70-78. 10.1038/jcbfm.2009.185, 2801771,2801771, 19724288.
15. Ouk T, Potey C, Laprais M, Gautier S, Hanf R, Darteil R, Staels B, Duriez P, Bordet R. PPARα is involved in the multitargeted effects of a pretreatment with atorvastatin in experimental stroke. Fundam Clin Pharmacol 2014, 28(3):294-302. 10.1111/fcp.12035, 23701370.
16. Ouk T, Gautier S, Pétrault M, Montaigne D, Maréchal X, Masse I, Devedjian JC, Deplanque D, Bastide M, Nevière R, Duriez P, Staels B, Pasquier F, Leys D, Bordet R. Effects of the PPAR-α agonist fenofibrate on acute and short-term consequences of brain ischemia. J Cereb Blood Flow Metab 2014, 34(3):542-51. 10.1038/jcbfm.2013.233, 24398933.
17. Fruchart JC, Duriez P, Staels B. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr Opin Lipidol 1999, 10:245-257. 10.1097/00041433-199906000-00007, 10431661.
18. Yoo HY, Chang MS, Mo H. RhoInduction of the rat Cu/Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid. Gene 1999, 234:87-91. 10.1016/S0378-1119(99)00176-6, 10393242.
19. Girnun GD, Domann FE, Moore SA, Robbins MEC. Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol Endocrinol 2002, 16:2793-2801. 10.1210/me.2002-0020, 12456800.
20. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, Staels B. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 1999, 274:32048-32054. 10.1074/jbc.274.45.32048, 10542237.
21. Deplanque D. Cell protection through PPAR nuclear receptor activation. Therapie 2004, 59:25-29. 10.2515/therapie:2004006, 15199664.
22. Besson VC, Chen XR, Plotkine M, Marchand-Verrecchia C. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury. Neuroscience Letters 2005, 388:7-12. 10.1016/j.neulet.2005.06.019, 16087294.
23. Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science 2001, 292:1160-1164. 10.1126/science.1059344, 11349148.
24. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, Jiang H, Zhang C, Lu M, Katakowski M, Feldkamp CS, Chopp M. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 2003, 53:743-751. 10.1002/ana.10555, 12783420.
25. Urbich C, Dernbach E, Zeiher AM, Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circ Res 2002, 90:737-744. 10.1161/01.RES.0000014081.30867.F8, 11934843.
26. Daw MI, Bortolotto ZA, Saulle E, Zaman S, Collingridge GL, Isaac JTR. Phosphatidylinositol 3 kinase regulates synapse specificity of hippocampal long-term depression. Nat Neurosci 2002, 5:835-836. 10.1038/nn903, 12161757.
27. Chen A, Liao WP, Lu Q, Wong WSF, Wong PT-H. Upregulation of dihydropyrimidinase-related protein 2, spectrin alpha II chain, heat shock cognate protein 70 pseudogene 1 and tropomodulin 2 after focal cerebral ischemia in rats-a proteomics approach. Neurochem Int 2007, 50:1078-1086. 10.1016/j.neuint.2006.11.008, 17196711.
28. Paumelle R, Staels B. Cross-talk between statins and PPARalpha in cardiovascular diseases: clinical evidence and basic mechanisms. Trends Cardiovasc Med 2008, 18(3):73-8. 10.1016/j.tcm.2008.01.001, 18436144.
29. Hu X, Rea HC, Wiktorowicz JE, Perez-Polo JR. Proteomic analysis of hypoxia/ischemia-induced alteration of cortical development and dopamine neurotransmission in neonatal rat. J Proteome Res 2006, 5:2396-2404. 10.1021/pr060209x, 3128998, 16944952.
30. Saito R, Smoot ME, Ono K, Ruscheinski J, Wang P-L, Lotia S, Pico AR, Bader GD, Ideker T. A travel guide to Cytoscape plugins. Nat Meth 2012, 9:1069-1076.
31. Ibáñez P, Bonnet A-M, Débarges B, Lohmann E, Tison F, Pollak P, Agid Y, Dürr A, Brice A. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 2004, 364:1169-1171. 10.1016/S0140-6736(04)17104-3, 15451225.
32. Lee Y-C, Lin C-H, Wu R-M, Lin M-S, Lin J-W, Chang C-H, Lai M-S. Discontinuation of statin therapy associates with Parkinson disease: a population-based study. Neurology 2013, 81:410-416. 10.1212/WNL.0b013e31829d873c, 23884037.
33. Kaneko K, Hachiya NS. The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions. Med Hypotheses 2006, 67:169-171. 10.1016/j.mehy.2006.01.019, 16516399.
34. Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003, 302:819-822. 10.1126/science.1087753, 14593166.
35. Murphy N, Yamamoto A, Henshall DC. Detection of 14-3-3zeta in cerebrospinal fluid following experimentally evoked seizures. Biomarkers 2008, 13:377-384. 10.1080/13547500802027971, 18484353.
36. Siman R, Roberts VL, McNeil E, Dang A, Bavaria JE, Ramchandren S, McGarvey M. Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest. Brain Research 2008, 1213:1-11. 2494615, 18456245.
37. Quinn CC, Gray GE, Hockfield S. A family of proteins implicated in axon guidance and outgrowth. J Neurobiol 1999, 41:158-164. 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.0.CO;2-0, 10504203.
38. Tonchev AB, Yamashima T, Zhao L, Okano HJ, Okano H. Proliferation of neural and neuronal progenitors after global brain ischemia in young adult macaque monkeys. Mol Cell Neurosci 2003, 23:292-301. 10.1016/S1044-7431(03)00058-7, 12812760.
39. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, Jiang H, Zhang C, Lu M, Katakowski M, Feldkamp CS, Chopp M. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 2003, 53:743-751. 10.1002/ana.10555, 12783420.
40. Llorente IL, Burgin TC, Pérez-Rodríguez D, Martínez-Villayandre B, Pérez-García CC, Fernández-López A. Unfolded protein response to global ischemia following 48 h of reperfusion in the rat brain: the effect of age and meloxicam. J Neurochem 2013, 127:701-710. 10.1111/jnc.12337, 23763503.
41. Descamps E, Petrault-Laprais M, Maurois P, Pages N, Bac P, Bordet R, Vamecq J. Experimental stroke protection induced by 4-hydroxybenzyl alcohol is cancelled by bacitracin. Neurosci Res 2009, 64:137-142. 10.1016/j.neures.2009.02.005, 19428693.
42. Yu S, Zhao J, Wang X, Lei S, Wu X, Chen Y, Wu J, Zhao Y. 4-Hydroxybenzyl alcohol confers neuroprotection through up-regulation of antioxidant protein expression. Neurochem Res 2013, 38:1501-1516. 10.1007/s11064-013-1052-x, 23624876.
43. Bordet R, Deplanque D, Maboudou P, Puisieux F, Pu Q, Robin E, Martin A, Bastide M, Leys D, Lhermitte M, Dupuis B. Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance. J Cereb Blood Flow Metab 2000, 20:1190-1196.
44. Sergeant N, Bombois S, Ghestem A, Drobecq H, Kostanjevecki V, Missiaen C, Wattez A, David J-P, Vanmechelen E, Sergheraert C, Delacourte A. Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach. J Neurochem 2003, 85:1581-1591. 10.1046/j.1471-4159.2003.01818.x, 12787077.
45. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13(11):2498-504. 10.1101/gr.1239303, 403769, 14597658.